Screening newborns for primary T-cell immunodeficiencies: consensus and controversy

Deborah J Accetta Pedersen Department of Pediatrics, Medical College of Wisconsin and the Children’s Research Institute, Medical College of Wisconsin, Milwaukee, WI 53226, USA; Department of Pediatrics, Medical College of Wisconsin and the Children’s Research Institute, Medical College of Wisconsin, Milwaukee, WI 53226, USA

James Verbsky Department of Pediatrics, Medical College of Wisconsin and the Children’s Research Institute, Medical College of Wisconsin, Milwaukee, WI 53226, USA; Department of Microbiology and Medical Genetics, Medical College of Wisconsin and the Children’s Research Institute, Medical College of Wisconsin, Milwaukee, WI 53226, USA; Department of Pediatrics, Medical College of Wisconsin and the Children’s Research Institute, Medical College of Wisconsin, Milwaukee, WI 53226, USA; Department of Microbiology and Medical Genetics, Medical College of Wisconsin and the Children’s Research Institute, Medical College of Wisconsin, Milwaukee, WI 53226, USA

John M Routes Department of Pediatrics, Medical College of Wisconsin and the Children’s Research Institute, Medical College of Wisconsin, Milwaukee, WI 53226, USA; Department of Microbiology and Medical Genetics, Medical College of Wisconsin and the Children’s Research Institute, Medical College of Wisconsin, Milwaukee, WI 53226, USA;[email protected]

Abstract

Newborn screening for early identification of T-cell lymphopenia and severe combined immunodeficiency has recently been recommended as an addition to the newborn screening programs in all states. This article will review the evidence supporting the use of this newborn screening test, and will outline the barriers to nationwide implementation, which include issues specific to this test and controversies regarding newborn screening in general.

Keywords::

Financial & competing interests disclosure

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.

Notes

Adapted with permission from Citation[6].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Screening newborns for primary T-cell immunodeficiencies: consensus and controversy

Information for

Open access

Opportunities

Help and information

Screening newborns for primary T-cell immunodeficiencies: consensus and controversy

Abstract

Financial & competing interests disclosure

Notes

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature